IQVIA and Propel abandon merger after FTC probe and injunction
2024-01-05
并购专利侵权
IQVIA is calling off its acquisition of Propel Media and health tech marketer DeepIntent. The companies agreed to abandon the deal after an FTC probe that resulted in a court-ordered injunction last week.
While the injunction was temporary, IQVIA and Propel would have had to convince FTC regulators in its internal administrative court trial to greenlight the deal.
“We faced a seemingly impossible decision of having to choose whether to continue investing our time and energy into what we unconditionally believe is a pro-competitive merger, or investing our precious, finite resources into building our business and better serving our clients,” DeepIntent CEO Chris Paquette wrote in an
open letter
to clients and partners on Thursday.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。